Search Results - Jeffrey W. Clark

Refine Results
  1. 1
    Headaches and Oral Contraceptives: Impact of Eliminating the Standard 7‐Day Placebo Interval

    Headaches and Oral Contraceptives: Impact of Eliminating the Standard 7‐Day Placebo Interval by Patricia J. Sulak, Sherilyn Willis, Thomas J. Kuehl, Andrea Coffee, Jeffrey W. Clark

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Quality of Informed Consent: a New Measure of Understanding Among Research Subjects

    Quality of Informed Consent: a New Measure of Understanding Among Research Subjects by Steven Joffe, E. Francis Cook, Paul D. Cleary, Jeffrey W. Clark, Jane C. Weeks

    Published 2001
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Familial Gastric Cancers

    Familial Gastric Cancers by Namrata Setia, Jeffrey W. Clark, Dan G. Duda, Theodore S. Hong, Eunice L. Kwak, John T. Mullen, Gregory Y. Lauwers

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Gemcitabine‐associated thrombotic microangiopathy

    Gemcitabine‐associated thrombotic microangiopathy by Benjamin D. Humphreys, Jeff P. Sharman, Joel Henderson, Jeffrey W. Clark, Peter Marks, Helmut G. Rennke, Andrew X. Zhu, Colm Magee

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Rapid Radiographic and Clinical Improvement After Treatment of a <i>MET</i>-Amplified Recurrent Glioblastoma With a Mesenchymal-Epithelial Transition Inhibitor

    Rapid Radiographic and Clinical Improvement After Treatment of a <i>MET</i>-Amplified Recurrent Glioblastoma With a Mesenchymal-Epithelial Transition Inhibitor by S. Andrew, Tracy T. Batchelor, Eunice L. Kwak, Jeffrey W. Clark, Daphne L. Wang, Keith D. Wilner, David N. Louis, A. John Iafrate

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma

    A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma by Charles S. Fuchs, Jeffrey W. Clark, David P. Ryan, M. Kulke, Haesook Kim, Craig C. Earle, Michele Vincitore, Robert J. Mayer, Keith Stuart

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Modes of transmission and evidence for viral latency from studies of human T-cell lymphotrophic virus type I in Japanese migrant populations in Hawaii.

    Modes of transmission and evidence for viral latency from studies of human T-cell lymphotrophic virus type I in Japanese migrant populations in Hawaii. by William A. Blattner, Abraham M. Y. Nomura, Jeffrey W. Clark, Gloria Y. F. Ho, Y Nakao, R C Gallo, Marjorie Robert-Guroff

    Published 1986
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    A Phase II trial of gemcitabine for metastatic neuroendocrine tumors

    A Phase II trial of gemcitabine for metastatic neuroendocrine tumors by Matthew H. Kulke, Haesook Kim, Jeffrey W. Clark, Peter C. Enzinger, Thomas J. Lynch, Jeffrey A. Morgan, Michele Vincitore, Ann Michelini, Charles S. Fuchs

    Published 2004
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Phase II study of the multitargeted antifolate LY231514 (ALIMTA™, MTA, pemetrexed disodium) in patients with advanced pancreatic cancer

    Phase II study of the multitargeted antifolate LY231514 (ALIMTA™, MTA, pemetrexed disodium) in patients with advanced pancreatic cancer by Kathy D. Miller, Joel Picus, Charles D. Blanke, William J. John, Jeffrey W. Clark, Lawrence N. Shulman, D. Thornton, Eric K. Rowinsky, Patrick J. Loehrer

    Published 2000
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Sorafenib: A Review of Four Phase I Trials in Patients with Advanced Refractory Solid Tumors

    Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Sorafenib: A Review of Four Phase I Trials in Patients with Advanced Refractory Solid Tumors by Dirk Strumberg, Jeffrey W. Clark, Ahmad Awada, Malcolm J. Moore, Heike Richly, Alain Hendlisz, Hal W. Hirte, Joseph P. Eder, Heinz‐Josef Lenz, Brian Schwartz

    Published 2007
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    Seroepidemiologic Studies Of Human T‐cell leukemia/lymphoma virus type I in Jamaica

    Seroepidemiologic Studies Of Human T‐cell leukemia/lymphoma virus type I in Jamaica by Jeffrey W. Clark, Arthur Ensroth, William A. Blattner, Carl Saxinger, Marjorie Robert‐Guroff, Robert C. Gallo, W. N. Gibbs, W. Lofters, Lois Lagranade, K DeCeulaer

    Published 1985
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Capecitabine Plus Erlotinib in Gemcitabine-Refractory Advanced Pancreatic Cancer

    Capecitabine Plus Erlotinib in Gemcitabine-Refractory Advanced Pancreatic Cancer by Matthew H. Kulke, Lawrence S. Blaszkowsky, David P. Ryan, Jeffrey W. Clark, Jeffrey A. Meyerhardt, Andrew X. Zhu, Peter C. Enzinger, Eunice L. Kwak, Alona Muzikansky, Colleen Lawrence, Charles S. Fuchs

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Phase II Study of Capecitabine, Oxaliplatin, and Erlotinib in Previously Treated Patients With Metastastic Colorectal Cancer

    Phase II Study of Capecitabine, Oxaliplatin, and Erlotinib in Previously Treated Patients With Metastastic Colorectal Cancer by Jeffrey A. Meyerhardt, Andrew X. Zhu, Peter C. Enzinger, David P. Ryan, Jeffrey W. Clark, Matthew H. Kulke, Craig C. Earle, Michele Vincitore, Ann Michelini, Susan Sheehan, Charles S. Fuchs

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    <i>O</i> 6-Methylguanine DNA Methyltransferase Deficiency and Response to Temozolomide-Based Therapy in Patients with Neuroendocrine Tumors

    <i>O</i> 6-Methylguanine DNA Methyltransferase Deficiency and Response to Temozolomide-Based Therapy in Patients with Neuroendocrine Tumors by Matthew H. Kulke, Jason L. Hornick, Christine Frauenhoffer, Susanne M. Hooshmand, David P. Ryan, Peter C. Enzinger, Jeffrey A. Meyerhardt, Jeffrey W. Clark, Keith Stuart, Charles S. Fuchs, Mark Redston

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma

    Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma by Andrew X. Zhu, Keith Stuart, Lawrence S. Blaszkowsky, Alona Muzikansky, Donald P. Reitberg, Jeffrey W. Clark, Peter C. Enzinger, Pankaj Bhargava, Jeffrey A. Meyerhardt, Kerry Horgan, Charles S. Fuchs, David P. Ryan

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Long-term Results of Intraoperative Electron Beam Irradiation (IOERT) for Patients With Unresectable Pancreatic Cancer

    Long-term Results of Intraoperative Electron Beam Irradiation (IOERT) for Patients With Unresectable Pancreatic Cancer by Christopher G. Willett, Carlos Fernández del Castillo, Helen A. Shih, Saveli Goldberg, Peter J. Biggs, Jeffrey W. Clark, Gregory Y. Lauwers, David P. Ryan, Andrew X. Zhu, Andrew L. Warshaw

    Published 2005
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC

    Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC by S.-H.I. Ou, Pasi A. Jänne, Cynthia Huang Bartlett, Yiyun Tang, D.-W. Kim, Gregory A. Otterson, Lucio Crinò, Paulina Selaru, D. P. Cohen, Jeffrey W. Clark, Gregory J. Riely

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Acquired Resistance to Crizotinib in NSCLC with MET Exon 14 Skipping

    Acquired Resistance to Crizotinib in NSCLC with MET Exon 14 Skipping by Rebecca S. Heist, Lecia V. Sequist, Darrell R. Borger, Justin F. Gainor, Ronald S. Arellano, Long P. Le, Dora Dias‐Santagata, Jeffrey W. Clark, Jeffrey A. Engelman, Alice T. Shaw, A. John Iafrate

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma

    A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma by David P. Ryan, Matthew H. Kulke, Charles S. Fuchs, Michael L. Grossbard, Steven R. Grossman, Jeffrey A. Morgan, Craig C. Earle, Ramesh A. Shivdasani, Haesook Kim, Robert J. Mayer, Jeffrey W. Clark

    Published 2001
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Prospective Study of Bevacizumab Plus Temozolomide in Patients With Advanced Neuroendocrine Tumors

    Prospective Study of Bevacizumab Plus Temozolomide in Patients With Advanced Neuroendocrine Tumors by Jennifer A. Chan, Keith Stuart, Craig C. Earle, Jeffrey W. Clark, Pankaj Bhargava, Rebecca A. Miksad, Lawrence S. Blaszkowsky, Peter C. Enzinger, Jeffrey A. Meyerhardt, Hui Zheng, Charles S. Fuchs, Matthew H. Kulke

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: